BERLIN — Psychosocial factors, such as anxiety and depression, are associated with an increased risk for both self-reported “clinical” and symptomatic, or “hard,” flare in inflammatory bowel disease (IBD), suggested a study of UK patients. The research was presented at the European Crohn’s and Colitis Organisation (ECCO) 2025 Congress…Read More
Does the time of day of immunotherapy infusions affect patients’ survival outcomes? A recent meta-analysis that examined data from over a dozen studies concluded that immunotherapy provided earlier in the day substantially improves progression-free and overall survival across a range of cancers, including metastatic melanoma, renal cell carcinoma…Read More
BERLIN — Induction therapy with subcutaneous guselkumab demonstrated significant efficacy in patients with moderately to severely active ulcerative colitis (UC), according to results from the phase 3, randomized, double-blind, placebo-controlled ASTRO study. Importantly, the study also showed that subcutaneous induction is consistent with intravenous (IV) induction of guselkumab in UC…Read More
Each morning on many vacations, Emily K. Osman, MD, would stay in her hotel room until she’d made all her patient phone calls and reviewed their test results. This often meant missing nearly half a day with her family. Palm trees may have been swaying outside…Read More
The British Medical Association (BMA) has conditionally accepted amendments to the 2025-2026 GP General Medical Services contract. Its GP Committee for England (GPCE) approved the changes in principle but insists on a written government commitment to renegotiate a new national contract within this Parliament. The proposed amendments…Read More